BARDA supports advanced development and regulatory approval/clearance for vaccines, therapeutics, and diagnostics to detect, prevent, and treat pandemic influenza infection. The BARDA Pandemic Influenza Preparedness and Response Strategy centers on four objectives: strategic implementation and deployment of the U.S. National Pre-pandemic Influenza Vaccine Stockpile; improved vaccines against pandemic influenza; better deployment, early availability, and novel deployment; and diagnostics. Read the Strategy to learn how BARDA plans to advance each of these areas to bolster national health security.